Diabetes is associated with higher mortality in liver transplant recipients with hepatocellular carcinoma.

被引:0
|
作者
Elsaqa, Marwan [1 ]
Carrero, Leandro Sierra [1 ]
Bonder, Alan [1 ]
Saberi, Behnam [1 ]
机构
[1] Beth Israel Deaconess Med Ctr, Gastroenterol & Hepatol, Boston, MA 02215 USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
202.1
引用
收藏
页码:9 / 9
页数:1
相关论文
共 50 条
  • [1] Diabetes is associated with higher mortality in liver transplant recipients with hepatocellular carcinoma
    Alsaqa, Marwan
    Carrero, Leandro Sierra
    Bonder, Alan
    Saberi, Behnam
    TRANSPLANTATION, 2024, 108 (9S)
  • [2] Hepatitis C virus quasispecies in liver transplant recipients with and without hepatocellular carcinoma.
    Gallegos-Orozco, JF
    Zhang, J
    Laskus, T
    Vargas, HE
    Mulligan, DC
    Reddy, KS
    Moss, A
    Rakela, J
    Byrne, TJ
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 181 - 181
  • [3] Clinical Significance of Solitary Pulmonary Nodules in Liver Transplant Recipients with Hepatocellular Carcinoma.
    Serrano, O.
    Bangdiwala, A.
    Vock, D.
    Kirchner, V.
    Yadav, K.
    Pugalendhi, A.
    Minja, E.
    Dunn, T.
    Finger, E.
    Matas, A.
    Kandaswamy, R.
    Payne, W.
    Pruett, T.
    Chinnakotla, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 461 - 461
  • [4] Early postoperative mortality in liver transplant recipients involving indications other than hepatocellular carcinoma. A retrospective cohort study
    Pozo-Laderas, J. C.
    Guler, I
    Rodriguez-Peralvarez, M.
    Robles, J. C.
    Mula, A.
    Lopez-Cillero, P.
    de la Fuente, C.
    MEDICINA INTENSIVA, 2021, 45 (07) : 395 - 410
  • [5] Predicting Mortality in Transplant Recipients with Hepatocellular Carcinoma
    Sasaki, K.
    Firl, D. J.
    Hashimoto, K.
    Fujiki, M.
    Diago-Uso, T.
    Quintini, C.
    Eghtesad, B.
    Fung, J. J.
    Miller, C. M.
    Aucejo, F. N.
    TRANSPLANTATION, 2017, 101 (05) : 379 - 379
  • [6] Sirolimus in Liver Transplant Recipients With Hepatocellular Carcinoma
    Grigg, Sam
    Gow, Paul
    Yeomans, Neville
    JOURNAL OF INVESTIGATIVE SURGERY, 2020, 33 (04) : 389 - 390
  • [7] Hepatocellular carcinoma as a independent risk factor for post transplant diabetes in liver recipients
    Bernardes, S. M.
    Goncalez Bovi, T.
    Colitti Lemos, F.
    Minatel Righetto, C.
    Russo Fiore, A.
    Teixeira Lot, L.
    Moura Neto, A.
    de Fatima Ferreira Santana Boin, I.
    DIABETOLOGIA, 2018, 61 : S586 - S587
  • [8] Use of Metformin in Liver Transplant Recipient With Hepatocellular Carcinoma.
    Choi, J.
    Lee, K.
    Rhu, J.
    Gil, E.
    Na, B.
    Oh, D.
    TRANSPLANTATION, 2014, 98 : 750 - 750
  • [9] Management of liver transplant patients with recurrence of hepatocellular carcinoma.
    Safak, Adem
    Karakaya, Emre
    Yildirim, Sedat
    Okyay, Ozan
    Boyvat, Fatih
    Tseveldorj, Nomingerel
    Boyacioglu, Sedat
    Haberal, Mehmet A.
    TRANSPLANTATION, 2024, 108 (9S)
  • [10] The impact of loco-regional therapy on long term outcomes of liver transplant recipients for hepatocellular carcinoma.
    Eshraghian, Ahad
    Taghavi, Alireza
    Nikeghbalian, Saman
    Nikoupour, Hamed
    Shamsaeefar, Alireza
    Malek-Hosseini, Seyed Ali
    TRANSPLANTATION, 2024, 108 (9S)